Model
Edge
Moonlake Immunotherapeutics
0001920545
Filing Type
4
Filing Date
4/9/2026
Updated
4/10/26, 4:06 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership